Lang Wu to Drug Administration Schedule
This is a "connection" page, showing publications Lang Wu has written about Drug Administration Schedule.
Connection Strength
0.037
-
Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q, Sun L, Luo B, Shang L, Chen W, Bai Y, Tang M, He M, Wu L, Ma Q, Hou D, He J. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial. Age Ageing. 2017 09 01; 46(5):767-773.
Score: 0.037